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Abstract
The mandatory quarantine imposed in response to the COVID-19 pandemic has been related 
to an increase in cases of thromboembolism in non-COVID-19 patients. Particularly in coun-
tries like Argentina where strict quarantine was mandated, individuals were far less likely to risk 
being outside or observing healthy practices that would maintain the exacerbation of diseases 
such as thromboembolism. We report the case of a patient with pulmonary thromboembolism 
without usual triggering causes during the quarantine period, related to a previously undiag-
nosed hypercoagulable condition.
Introduction
Quarantine imposed by different countries due to the COVID-19 pandemic has resulted 
in increased cases of thromboembolism in non-COVID-19 patients. [1,2] In Argentina, to 
prevent the spread of the coronavirus, the president announced mandatory quarantine 
and citizens with jobs described as non-essential had to be confined to their usual res-
idences or to the place where they were at when he announced nationwide lockdown. 
Citizens had to refrain from attending their workplaces except for essential workers and 
emergency care providers. Moreover, any public or private event or activity as well as 
schooling and social gatherings were cancelled. People were not allowed to travel on 
the roads and freeways unless they had to carry out the essential jobs described on the 
official list, like the case of transportation of essential cleaning supplies, medicine, and 
food. [3]
Case Presentation
Thirty-seven days after the mandatory quarantine imposed in Argentina after March 
2020, which forced everyone except for essential workers and employees of other emer-
gency care situations into lockdown, a 64-year-old man living in Departamento Unión 
of Córdoba Province (without community viral circulation) consulted his primary care 
physician for acute dyspnea to minor habitual efforts. [3] The patient realized the symp-
toms after a short postprandial walk. Two hours earlier, he had participated in mild 
physical activities without experiencing any symptoms. His medical records were signif-
icant: Type II diabetes, high blood pressure, mild carotid vascular disease, and obesity. 
The patient was current with all scheduled metabolic and blood pressure checkups as 
well as regularly administered doses of aspirin, except for the last seven days, which he 
had forgotten .Ten years before, he had suffered from deep vein thrombosis during a long 
flight. On that occasion, he had not been diagnosed with any predictor. The patient did 
not have any problems with being in lockdown, but his physical activity had fallen sig-
nificantly since the beginning of the lockdown. 
The patient was sent to a cardiology clinic, where he was admitted 48 hours after the 
initial symptoms because of continuing symptoms. The delay in admittance was due in 
large part because of his fear of contracting SARS-CoV-2. He did not have fever or any 
other respiratory symptoms, or trips to areas with SARS-CoV-2, viral outbreak, or close 
contact with a patient with a COVID-19 diagnosis. He had no angina, palpitations, syn-
cope, or dyspnea at rest. The patient did not have any other symptoms at rest, and his 
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axillary temperature was 36.4 °C and his radial pulse rate was 100 bpm. The patient had slight arterial oxygen desatu-
ration by oximetry (89% with ambient air) and an S3 on auscultation, without physical signs of venous thrombosis. The 
findings of his examination and laboratory tests are summarized in Table 1.
Blood pressure 100/70 mmhg
Heart Rate 110 lpm, regular, rhythmic
Respiratory Rate 18 rpm at rest
Saturation O2 Oximetry 89% with ambient air
Temperature 36.4°C
ECG  Sinusal Tachycardia
D Dimer 198 ng/ml (VN < 200 ng/ml)
Protrombine Time 21.1 seg RIN 1,66
PCR < 6 mg/l
Glucemia 128 mg% 
Table 1. Patient Examinations and Lab Findings.
The diagnostic impression was hypoxemic respiratory failure secondary to acute pulmonary thromboembolism (PE). 
The risk chances of PE were calculated with the GENEVA Score at 8 points (moderate risk), the Wells Score at 9 points 
(high risk of PE), and the PESI Score at 114 points (high risk).
A POCUS pulmonary ultrasound and a POCUS echocardiogram showed an “A” profile at the pulmonary level (BLUE 
Protocol). [4] It also showed evidence of a left ventricular hypertrophy, with hyperdynamic systolic function of the left 
ventricle and dilation and systolic dysfunction of the right ventricle. At this, the patient received anticoagulation.
A formal subsequent venous ultrasound did not find evidence of deep vein thrombosis. However, a chest angio-tomog-
raphy revealed a pulmonary artery caliber of 30mm in the trunk that was found to be patent as well as the right and left 
main branches. Hypodense material which partially blocked the vascular lumen, compatible with acute PE, was found 
in the lobar and segmental branches of all lobes (Figure 1 and Figure 2).
Figure 1. Lung angio-tomography
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Figure 2. Lung angio-tomography
A SARS-CoV-2 PCR was not performed because the patient did not present with the local case definition criteria at 
the time of admission. Anticoagulation with sodium heparin, oxygen at 3L/minute, and boluses of saline crystalloids 
were administered with good outcome. The subsequent workup for other patient-related factors predisposing him for 
venous thromboembolism revealed Antiphospholipid Syndrome with evidence of a circulating anticoagulant (lupus 
anticoagulant) (Table 2). It was decided that the patient was going to remain anticoagulated in the long term. [5]
Circulating anticoagulant LA1 126
LA2 50, normalized reason 2.54
Protein C 112 %
Ac Against phospholipids  IgC 1.7 (normal)
Ac Agains phospholipids  IgM 1 Normal
Ac Anticardiolipin igG,IgM Negative
Ac Antinuclear Negative
Reumatoid Factor Negative
Protein S 88% normal 
Table 2. Subsequent workup for other patient-related factors.
Discussion
This case study of acute PE contributes to the field by offering new evidence of the increased risk of high-risk throm-
boembolic situations. In this case, the situation presented in a patient with unusual triggering factors under the con-
ditions of decreased physical activity due to the SARS-CoV-2 pandemic quarantine with the presence of Antiphos-
pholipid Syndrome. [1-3] A delay in consulting a physician due to fear of becoming infected while visiting health care 
areas increased this risk. Cases such as the one described above show the need to evaluate the risk/benefit to health 
outcomes from strict/mandatory quarantines in areas without viral circulation, and the need to give sound advice to 
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patients with known risks. In the case study described, the risk of developing thromboembolism in quarantine can be 
equated with the risk a person can have during a long flight.
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